[1] |
Prodromidou A, Kathopoulis N, Zacharakis D, et al. Tubal Endometriosis: From Bench to Bedside, A Scoping Review[J]. J Pers Med, 2022, 12(3):362. doi: 10.3390/jpm12030362.
|
[2] |
Giannella L, Marconi C, Di Giuseppe J, et al. Malignant Transformation of Postmenopausal Endometriosis: A Systematic Review of the Literature[J]. Cancers (Basel), 2021, 13(16):4026. doi: 10.3390/cancers13164026.
|
[3] |
Wang H, Chen C, Wang D, et al. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer[J]. BMC Cancer, 2023, 23(1):1210. doi: 10.1186/s12885-023-11641-4.
pmid: 38066448
|
[4] |
Krawczyk N, Banys-Paluchowski M, Schmidt D, et al. Endometriosis-associated Malignancy[J]. Geburtshilfe Frauenheilkd, 2016, 76(2):176-181. doi: 10.1055/s-0035-1558239.
|
[5] |
Harris CM, Singleton MP, Samulski T, et al. Primary peritoneal clear cell carcinoma arising in the setting of abdominal wall Endometriosis: A case report and review of the literature[J]. Gynecol Oncol Rep, 2024, 53:101370. doi: 10.1016/j.gore.2024.101370.
|
[6] |
张玮玥, 杨静, 季佳楠. 腹壁子宫内膜异位症相关性透明细胞癌的诊治进展[J]. 国际妇产科学杂志, 2024, 51(1):60-65. doi: 10.12280/gjfckx.20230712.
|
[7] |
Marks EI, Brown VS, Dizon DS. Genomic and Molecular Abnormalities in Gynecologic Clear Cell Carcinoma[J]. Am J Clin Oncol, 2020, 43(2):139-145. doi: 10.1097/COC.0000000000000641.
|
[8] |
Batista MP, Roffé M, Romero I, et al. Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression[J]. BMC Cancer, 2023, 23(1):613. doi: 10.1186/s12885-023-11095-8.
pmid: 37400764
|
[9] |
郭婕莹, 蔡云朗. 卵巢子宫内膜异位症恶变的相关研究进展[J]. 东南大学学报(医学版), 2024, 43(1):147-151. doi: 10.3969/j.issn.1671-6264.2024.01.024.
|
[10] |
Sun Y, Liu G. Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?[J]. J Cancer, 2021, 12(22):6773-6786. doi: 10.7150/jca.61107.
pmid: 34659566
|
[11] |
Tang L, Bian C. Research progress in endometriosis-associated ovarian cancer[J]. Front Oncol, 2024, 14:1381244. doi: 10.3389/fonc.2024.1381244.
|
[12] |
Negrão E, Flor-de-Lima B, Duarte AL, et al. Ovarian clear cell carcinoma arising in a large endometrioma-A case report with pathological correlation and literature review[J]. Radiol Case Rep, 2022, 17(8):2806-2811. doi: 10.1016/j.radcr.2022.05.015.
|
[13] |
Ono M, Fukuda M, Yamanoi K, et al. Clinical significance of initial symptoms in endometriosis-associated ovarian cancer[J]. Turk J Obstet Gynecol, 2024, 21(1):28-36. doi: 10.4274/tjod.galenos.2024.59019.
|
[14] |
Murakami K, Kotani Y, Nakai H, et al. Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy[J]. Cancers (Basel), 2020, 12(6):1676. doi: 10.3390/cancers12061676.
|
[15] |
Kundur M, Bhati P, Girish BK, et al. Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes[J]. Ecancermedicalscience, 2023, 17:1591. doi: 10.3332/ecancer.2023.1591.
pmid: 37799950
|
[16] |
Fujiwara S. Clinical perspectives of rare ovarian tumors: clear cell ovarian cancer[J]. Jpn J Clin Oncol, 2023, 53(8):664-672. doi: 10.1093/jjco/hyad057.
pmid: 37288485
|
[17] |
Murakami K, Kotani Y, Shiro R, et al. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts[J]. Int J Clin Oncol, 2020, 25(1):51-58. doi: 10.1007/s10147-019-01536-5.
pmid: 31473885
|